SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-23-001846
Filing Date
2023-10-16
Accepted
2023-10-16 13:13:43
Documents
15
Period of Report
2023-10-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm   iXBRL 8-K 24609
2 PRESS RELEASE lxrp_ex991.htm EX-99 10923
  Complete submission text file 0001640334-23-001846.txt   162624

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20231003.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20231003_lab.xml EX-101.LAB 14635
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20231003_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20231003_pre.xml EX-101.PRE 9260
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20231003_def.xml EX-101.DEF 2099
9 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_8k_htm.xml XML 3599
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 231326997
SIC: 2834 Pharmaceutical Preparations